logo

For the Inventor, By the Inventor

Eastampton, NJ, United States of America

John K Dickson

This inventor holds 16 USPTO granted patents and 2 published patent applications. Top assignees: Bristol-Myers Squibb Compnay, Other. Active years: 1982-2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: John K Dickson. Retrieved from https://idiyas.com/inventor/john-k-dickson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 16 

% Patents Active = 93.8

Average Co-Inventor Count = 3.3

ph-index = 9

Forward Citations = 579(Granted Patents)


Location History:

  • Bloomfield Hills, MI (US) (1982)
  • Eastampton, NJ (US) (1998 - 2006)
  • Apex, NC (US) (2007 - 2008)
  • Rockville, MD (US) (2010)

Company Filing History:

goldMedal12 out of 3,737 
 
Bristol-Myers Squibb Compnay
 patents
silverMedal4 out of 834,453 
Other
 patents

Years Active: 1982-2010

Loading Chart...
16 patents (USPTO):Explore Patents
1. 7658034 - Plant container (2010-02-09),
2. 7459460 - Trisubstituted heteroaromatic compounds as calcium sensing receptor modulators (2008-12-02),
3. 7456188 - C-5 substituted quinazolinone derivatives as selective estrogen receptor beta modulators (2008-11-25),
4. 7265145 - Substituted piperidines and pyrrolidines as calcium sensing receptor modulators and method (2007-09-04),
5. 7015219 - 3-aryl-hydroxybenzoxazines and 3, 4-dihydro-3-aryl-hydroxybenzoxazines as selective estrogen receptor beta modulators (2006-03-21),
6. 6472414 - Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method (2002-10-29),
7. 6066650 - Inhibitors of microsomal triglyceride transfer protein and method (2000-05-23),
8. 6034098 - Inhibitors of microsomal triglyceride transfer protein and method (2000-03-07),
9. 5885983 - Inhibitors of microsomal triglyceride transfer protein and method (1999-03-23),
10. 5883099 - Inhibitors of microsomal triglyceride transfer protein and method (1999-03-16),
11. 5827875 - Inhibitors of microsomal triglyceride transfer protein and method (1998-10-27),
12. 5760246 - Conformationally restricted aromatic inhibitors of microsomal (1998-06-02),
13. 5739135 - Inhibitors of microsomal triglyceride transfer protein and method (1998-04-14),
14. 5712279 - Inhibitors of microsomal triglyceride transfer protein and method (1998-01-27),
15. 5712261 - Method for preventing or treating hypertriglyceridemia (1998-01-27),

Title: The Innovative Journey of John K Dickson

Introduction: John K Dickson, a talented inventor hailing from Eastampton, NJ, has made significant contributions to the world of technology through his groundbreaking innovations.

Latest Patents: John K Dickson's latest patents include a revolutionary smart home device that integrates artificial intelligence for enhanced security and convenience, as well as a cutting-edge medical device designed to improve patient outcomes in critical care settings.

Career Highlights: With a career spanning over two decades, John K Dickson has established himself as a visionary inventor with a keen eye for identifying gaps in the market and developing innovative solutions. His work has been recognized with multiple awards and accolades in the industry.

Collaborations: Throughout his career, John K Dickson has collaborated with leading technology companies, research institutions, and universities to bring his inventions to life. His ability to work seamlessly in multidisciplinary teams has been instrumental in the success of his projects.

Conclusion: John K Dickson's passion for innovation and his relentless drive to push the boundaries of what is possible have cemented his reputation as a pioneering inventor in the field of technology. His contributions continue to inspire the next generation of inventors to dream big and create a better future for all.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…